THU0110 Affinity and potency of the anti-NKG2A MAB NNC141-0100: Implications for mabel and dosing in the first-in-man trial in rheumatoid arthritis
Alifrangis, L., André, P., Pascal, V., Bonnet, E., Radzikowski, L., Petersen, M.B., Bléry, M.
Published in Annals of the rheumatic diseases (01.06.2013)
Published in Annals of the rheumatic diseases (01.06.2013)
Get full text
Journal Article
PO2-3: Multiple doses of a reversible albumin-binding growth hormone derivative demonstrate no differences in PK and PD between Japanese and non-Asian subjects
Højby Rasmussen, M, Olsen, M.W.B, Alifrangis, L, Klim, S, Suntum, M
Published in Growth hormone & IGF research (01.10.2014)
Published in Growth hormone & IGF research (01.10.2014)
Get full text
Journal Article
Structure−Property Model for Membrane Partitioning of Oligopeptides
Alifrangis, Lene Hjorth, Christensen, Inge T, Berglund, Anders, Sandberg, Maria, Hovgaard, Lars, Frokjaer, Sven
Published in Journal of medicinal chemistry (13.01.2000)
Published in Journal of medicinal chemistry (13.01.2000)
Get full text
Journal Article
A phase I study of Sym021, an anti-PD-1 antibody (Ab), alone and in combination with Sym022 (anti-LAG-3) or Sym023 (anti-TIM-3)
Spreafico, A., Janku, F., Rodon, J.A., Tolcher, A.W., Chandana, S.R., Oliva, M., Musalli, S., Knauss, L., Kragh, M., Alifrangis, L., Fröhlich, C., Melander, M.C., Blondal, T., Pedersen, M.W., Lantto, J., Wood, D., Nadler, P.I., Horak, I.D., Siu, L.L., Lakhani, N.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
1197P - A phase I study of Sym021, an anti-PD-1 antibody (Ab), alone and in combination with Sym022 (anti-LAG-3) or Sym023 (anti-TIM-3)
Spreafico, A., Janku, F., Rodon, J.A., Tolcher, A.W., Chandana, S.R., Oliva, M., Musalli, S., Knauss, L., Kragh, M., Alifrangis, L., Fröhlich, C., Melander, M.C., Blondal, T., Pedersen, M.W., Lantto, J., Wood, D., Nadler, P.I., Horak, I.D., Siu, L.L., Lakhani, N.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
1490PDA phase Ia/IIa trial of Sym015, a MET antibody mixture, in patients with advanced solid tumours
Camidge, D R, Janku, F, Bueno, A Martinez, Catenacci, D V, Lee, J, Lee, S-H, Chung, H C, Dowlati, A, Rohrberg, K S, Felip Font, E, Garralda, E, Kang, Y-K, Moon, Y W, López Criado, M, Chiu, C-F, Poulsen, T T, Rudbæk, H, Alifrangis, L, Dalal, R P, Patnaik, A
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
1197PA phase I study of Sym021, an anti-PD-1 antibody (Ab), alone and in combination with Sym022 (anti-LAG-3) or Sym023 (anti-TIM-3)
Spreafico, A, Janku, F, Rodon, J A, Tolcher, A W, Chandana, S R, Oliva, M, Musalli, S, Knauss, L, Kragh, M, Alifrangis, L, Fröhlich, C, Melander, M C, Blondal, T, Pedersen, M W, Lantto, J, Wood, D, Nadler, P I, Horak, I D, Siu, L L, Lakhani, N
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
1490PD - A phase Ia/IIa trial of Sym015, a MET antibody mixture, in patients with advanced solid tumours
Camidge, D.R., Janku, F., Bueno, A Martinez, Catenacci, D.V., Lee, J., Lee, S.-H., Chung, H.C., Dowlati, A., Rohrberg, K.S., Felip Font, E., Garralda, E., Kang, Y.-K., Moon, Y.W., López Criado, M., Chiu, C.-F., Poulsen, T.T., Rudbæk, H., Alifrangis, L., Dalal, R.P., Patnaik, A.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
A phase Ia/IIa trial of Sym015, a MET antibody mixture, in patients with advanced solid tumours
Camidge, D.R., Janku, F., Bueno, A Martinez, Catenacci, D.V., Lee, J., Lee, S.-H., Chung, H.C., Dowlati, A., Rohrberg, K.S., Felip Font, E., Garralda, E., Kang, Y.-K., Moon, Y.W., López Criado, M., Chiu, C.-F., Poulsen, T.T., Rudbæk, H., Alifrangis, L., Dalal, R.P., Patnaik, A.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
The synthesis and SAR of 2-arylsulfanyl-phenyl piperazinyl acetic acids as glyT-1 inhibitors
Smith, Garrick, Ruhland, Thomas, Mikkelsen, Gitte, Andersen, Kim, Christoffersen, Claus Tornby, Alifrangis, Lene Hjorth, Mørk, Arne, Wren, Stephen P, Harris, Neil, Wyman, Barry M, Brandt, Guillaume
Published in Bioorganic & medicinal chemistry letters (02.08.2004)
Published in Bioorganic & medicinal chemistry letters (02.08.2004)
Get full text
Journal Article
Parents' perceptions, attitudes and acceptability of treatment of childhood malaria with artemisinin combination therapies in ghana
Adjei, G O, Darkwah, A K, Goka, B Q, Bart-Plange, C, Alifrangis, M L, Kurtzhals, J A L, Rodrigues, O P
Published in Ghana medical journal (01.09.2009)
Get full text
Published in Ghana medical journal (01.09.2009)
Journal Article
New alpha(1)-adrenoceptor antagonists derived from the antipsychotic sertindole - carbon-11 labelling and pet examination of brain uptake in the cynomolgus monkey
Balle, Thomas, Halldin, Christer, Andersen, Linus, Hjorth Alifrangis, Lene, Badolo, Lassina, Gjervig Jensen, Klaus, Chou, Yuan-Wha, Andersen, Kim, Perregaard, Jens, Farde, Lars
Published in Nuclear medicine and biology (01.04.2004)
Published in Nuclear medicine and biology (01.04.2004)
Get full text
Journal Article